JPMorgan Chase presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

The first week of JPMorgan Chase’s mandatory return-to-office (RTO) policy has been anything but smooth, with employees voicing frustration over workspace shortages, unreliable Wi-Fi ...

JPMorgan Chase & Co. has a 12-month low of $179.20 and a 12-month high of $280.25. The company has a current ratio of 0.88, a quick ratio of 0.89 and a debt-to-equity ratio of 1.24.

JPMorgan Chase (NYSE: JPM) is the amalgam of two iconic names in the finance industry. The company is well respected and has been executing well. But is that enough of a reason to buy the stock?

JPMorgan Chase has staying power thanks not only to its massive scale, but also because of switching costs. The company’s profitability is better than its biggest competitors. Impressive ...

A JPMorgan Chase employee was fired—albeit briefly—after publicly questioning CEO Jamie Dimon about the bank’s return-to-office (RTO) policy during a town hall A JPMorgan Chase employee was ...

JPMorgan Chase & Co. has a fifty-two week low of $179.20 and a fifty-two week high of $280.25. The firm’s 50-day simple moving average is $258.55 and its 200 day simple moving average is $237.33.

It’s the first week of JPMorgan Chase’s return-to-office mandate that obliges thousands of people to come back in five days a week, and so far the adjustment has been less than smooth.

Large banks are exposed to the broader economy Large banks like JPMorgan Chase and Wells Fargo have relationships with consumers and businesses in nearly every sector of the economy, so if ...

JPMorgan Chase & Co. (JPM) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

In this episode, Dan Mendelson, CEO of Morgan Health, joins Scott Becker to discuss how Morgan Health, a division of JPMorgan Chase, is revolutionizing employer-sponsored healthcare. From ...